The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy
about
Immunotherapy of Childhood SarcomasMechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer ImmunotherapyActive immunization with human interleukin-15 induces neutralizing antibodies in non-human primates.Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.IL-15 Activates the Jak3/STAT3 Signaling Pathway to Mediate Glucose Uptake in Skeletal Muscle Cells.Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.Harnessing NK Cell Memory for Cancer Immunotherapy.Genetically Engineered Multivalent Proteins for Targeted Immunotherapy.The γ c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response.Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.Highly Selective Cleavage of Cytokines and Chemokines by the Human Mast Cell Chymase and Neutrophil Cathepsin G.NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).Epigenetic Maintenance of Acquired Gene Expression Programs during Memory CD8 T Cell Homeostasis.CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.First-in-human Phase 1 Clinical Study of the IL-15 Superagonist Complex ALT-803 to Treat Relapse after Transplantation.Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models.IL-2 and Beyond in Cancer Immunotherapy.Out-sourcing for Trans-presentation: Assessing T Cell Intrinsic and Extrinsic IL-15 Expression with Il15 Gene Reporter Mice.Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 BlockadeDistinct human circulating NKp30FcεRIγCD8 T cell population exhibiting high natural killer-like antitumor potential
P2860
Q26795369-B79E6E9B-5115-4C58-812D-3BD02B0455FDQ28084138-379CD659-557C-4CAC-BA56-4B5F78F31618Q36145575-3D2B609B-EEE8-42F5-AF0D-6D6F42C08BFAQ36539682-0ABBB294-3BA0-4B11-A3E2-12D31CBFA9E1Q37741534-CB8444DF-DF62-44D6-9E3C-567ED8579263Q38542034-4F1FFBE9-81D2-4693-ADD4-2AC0DD9EB966Q38722387-3AC126DE-5D1F-4BA7-98F5-51238169797FQ38753973-0380AA77-CEC2-4BEC-9049-41085647CBA9Q38988913-1696372C-2368-43EE-9949-965965220B42Q42416567-FB28F775-7365-4E40-9657-F5A7FB5481E4Q45797119-F935BC51-36B9-401C-8AFF-5939A41B3671Q47156322-EB52C97A-5CFE-46B1-96A1-6335098D484BQ47201640-8C09AE75-79A7-473D-9415-35031BB5A946Q48094970-F701559A-53A0-4242-BA56-3455E0BE42E6Q49333274-2105829D-1F04-4EE8-AF1D-B48CFD837CF6Q49376152-28DAA99E-6D97-4DC9-A4B0-703C301522FAQ49788177-A03C4DA7-20DD-4C43-BBD0-1AF32C09CBA6Q49791810-C1C6C2F9-B458-44F7-8091-E0C40EC448E1Q49919933-EB52CF0B-9884-411E-931B-97B39A592566Q50004232-8C57B157-343C-4631-A55B-A7E8B7D0CDE6Q50532765-17D8FF3B-212E-4173-9D6F-B189B7A60BABQ56967396-74E03B23-1008-4552-8447-DF04AB87A1B8Q57270695-4FF45A5B-F0A9-45BB-811D-A5976C6352EA
P2860
The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The shared and contrasting rol ...... mplications for cancer therapy
@ast
The shared and contrasting rol ...... mplications for cancer therapy
@en
The shared and contrasting rol ...... mplications for cancer therapy
@nl
type
label
The shared and contrasting rol ...... mplications for cancer therapy
@ast
The shared and contrasting rol ...... mplications for cancer therapy
@en
The shared and contrasting rol ...... mplications for cancer therapy
@nl
prefLabel
The shared and contrasting rol ...... mplications for cancer therapy
@ast
The shared and contrasting rol ...... mplications for cancer therapy
@en
The shared and contrasting rol ...... mplications for cancer therapy
@nl
P2860
P3181
P1476
The shared and contrasting rol ...... mplications for cancer therapy
@en
P2093
T. A. Waldmann
P2860
P304
P3181
P356
10.1158/2326-6066.CIR-15-0009
P407
P577
2015-03-01T00:00:00Z